Elicio Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.91

-0.09 (-2.25%)

As of Jun 30, 10:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +719.4% upside

Low Target $22.50

Average Target $32.04

High Target $35.39

Current Price $3.91

Current
$3.91

Target
$32.04

$22.50 $32.04 avg $35.39

Scenario Analysis

Bear Case

$22.50

475.4%

Low target

Base Case

$32.04

+719.4%

Avg target

Bull Case

$35.39

+805.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$16.00

-75.6% from high

52-Week Low

$2.66

+47.0% from low

Target vs 52W High

$32.04

+100.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%